Sellas Life Sciences Group Inc (SLS)

11:47 AM

Smart tools for monitoring SELLAS Life Sciences Group Inc.’s price actionEarnings Growth Report & Stepwise Swing Trade Plans - newser.com

11:47 AM

11:44 AM

Quantitative breakdown of SELLAS Life Sciences Group Inc. recent moveWeekly Trend Report & Low Drawdown Investment Strategies - newser.com

11:44 AM

10:58 AM

What technical models suggest about SELLAS Life Sciences Group Inc.’s comebackMarket Activity Report & Real-Time Market Trend Scan - newser.com

10:58 AM

09:33 AM

What analyst consensus says on SELLAS Life Sciences Group Inc. stockChart Signals & Risk Managed Investment Signals - newser.com

09:33 AM

08:57 AM

Using R and stats models for SELLAS Life Sciences Group Inc. forecastingTrade Signal Summary & Capital Efficient Trading Techniques - newser.com

08:57 AM

08:40 AM

SELLAS to present CDK9 inhibitor data for T-cell leukemia at ESMO - Investing.com Australia

08:40 AM

08:22 AM

How SELLAS Life Sciences Group Inc. stock valuations compare to rivalsQuarterly Portfolio Summary & Weekly High Return Stock Opportunities - newser.com

08:22 AM

08:08 AM

How institutional ownership impacts SELLAS Life Sciences Group Inc. stockPortfolio Update Summary & Target Return Focused Stock Picks - newser.com

08:08 AM

08:04 AM

SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncology (ESMO) Congress 2025 - GlobeNewswire

08:04 AM

08:00 AM

7.9w survival — SELLAS' SLS009 prolongs life in T-PLL vs 4.4w venetoclax; poster at ESMO Oct 18 - Stock Titan

08:00 AM

Oct 10, 2025

What data driven models say about SELLAS Life Sciences Group Inc.’s futureMarket Trend Review & Weekly Momentum Stock Picks - newser.com

Oct 10, 2025

Oct 10, 2025

Using data models to predict SELLAS Life Sciences Group Inc. stock movementJuly 2025 Decliners & Precise Entry and Exit Recommendations - newser.com

Oct 10, 2025

Oct 09, 2025

How to integrate SELLAS Life Sciences Group Inc. into portfolio analysis toolsPortfolio Performance Report & High Return Trade Guides - newser.com

Oct 09, 2025

Oct 09, 2025

Published on: 2025-10-09 03:27:21 - newser.com

Oct 09, 2025

Oct 09, 2025

Published on: 2025-10-09 03:07:14 - newser.com

Oct 09, 2025

Oct 07, 2025

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Sees Significant Decrease in Short Interest - Defense World

Oct 07, 2025

Oct 06, 2025

Multi factor analysis applied to SELLAS Life Sciences Group Inc.July 2025 Momentum & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

Using Python tools to backtest SELLAS Life Sciences Group Inc. strategies2025 Dividend Review & Free Accurate Trade Setup Notifications - newser.com

Oct 06, 2025

Oct 06, 2025

Can SELLAS Life Sciences Group Inc. (RXK3) stock double in coming years2025 Short Interest & Stock Market Timing Techniques - newser.com

Oct 06, 2025

Oct 06, 2025

Published on: 2025-10-06 05:59:31 - newser.com

Oct 06, 2025

Oct 03, 2025

SELLAS Extends Times Square Sublease Agreement - TipRanks

Oct 03, 2025

Oct 03, 2025

Why SELLAS Life Sciences Group Inc. (RXK3) stock benefits from AI revolutionEarnings Risk Summary & Community Consensus Picks - newser.com

Oct 03, 2025

Oct 03, 2025

Published on: 2025-10-03 03:10:59 - newser.com

Oct 03, 2025

Oct 03, 2025

Chart based analysis of SELLAS Life Sciences Group Inc. trendsJuly 2025 Patterns & Weekly Top Gainers Trade List - newser.com

Oct 03, 2025

Oct 03, 2025

Is SELLAS Life Sciences Group Inc. stock bottoming out2025 Buyback Activity & Daily Profit Focused Screening - newser.com

Oct 03, 2025

Oct 02, 2025

Published on: 2025-10-02 22:11:46 - newser.com

Oct 02, 2025

Oct 02, 2025

Will SELLAS Life Sciences Group Inc. (RXK3) stock test record highs in 20252025 Volume Leaders & High Conviction Investment Ideas - newser.com

Oct 02, 2025

Oct 01, 2025

SELLAS Life Sciences Group to Host Virtual R&D Day on October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 Program Update - Sahm

Oct 01, 2025

Oct 01, 2025

SELLAS Life Sciences to host virtual R&D day on AML treatments - Investing.com Nigeria

Oct 01, 2025

Sep 30, 2025

How Product Roadmap Could Affect Music Broadcast Limiteds Future ValueResistance Zone Identification & Free Stock Education Platform for New Investors - earlytimes.in

Sep 30, 2025

Sep 30, 2025

SELLAS Life Sciences to host virtual R&D day on AML treatments By Investing.com - Investing.com South Africa

Sep 30, 2025

Sep 30, 2025

What drives SELLAS Life Sciences Group Inc RXK3 stock priceHigh Beta Stocks & Fast Growing Investment Plans - earlytimes.in

Sep 30, 2025

Sep 30, 2025

SELLAS Life Sciences Group to Host Virtual R&D Day on - GlobeNewswire

Sep 30, 2025

Sep 30, 2025

Major AML Treatment Updates: SELLAS Life Sciences to Reveal Phase 3 REGAL Results & New Drug Progress - Stock Titan

Sep 30, 2025

Sep 30, 2025

Published on: 2025-09-30 01:16:34 - newser.com

Sep 30, 2025

Sep 30, 2025

What high frequency data says about SELLAS Life Sciences Group Inc.Market Activity Recap & Weekly Momentum Picks - newser.com

Sep 30, 2025

Sep 29, 2025

Published on: 2025-09-29 11:38:19 - newser.com

Sep 29, 2025

Sep 29, 2025

Published on: 2025-09-29 09:42:54 - newser.com

Sep 29, 2025